Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (4): 539-541    DOI: 10.12891/ceog4532.2019
Original Research Previous articles | Next articles
Leukemia inhibitory factor, glycodelin, and HOXA-10 in gestational diabetes
Y. Aydin1, *(), S. Uludağ2, A. Atis4, S. Uludağ2, S. Ilvan3
1Obstetrics and Gynecology, Medicana Hospital, Istanbul, Turkey
2Obstetrics and Gynecology, Cerrahpasa Medical Faculty, Istanbul, Turkey
3Histopatholoy, Cerrahpasa Medical Faculty, Istanbul, Turkey
4Obstetrics and Gynecology, Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey
Download:  PDF(187KB)  ( 184 ) Full text   ( 5 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Purpose of investigation: The authors aimed to localize glycodelin, leukemia inhibitory factor (LIF), and HOXA-10 in term placentas and study the relationship between these markers and maternal gestational diabetes. Materials and Methods: Following labor, placentas from 12 pregnant women with gestational diabetes and 15 healthy pregnant women were collected, fixed, and paraffin-embedded, and immunohistochemical studies were performed. Two independent researchers examined the specimens under light microscopy. Immunoreactive scores were calculated and compared. Results: Glycodelin and HOXA-10 were stained in the decidua, and LIF was stained both in the trophoblast and in the decidua of term placentas. The three markers’ immunoreactive scores were not different between pregnant women with gestational diabetes and the healthy controls. Conclusion: Glycodelin and HOXA-10 were produced by maternal decidual cells; LIF was produced by both trophoblasts and maternal decidual cells. Glycodelin, HOXA-10, and LIF are not related to the pathophysiology of gestational diabetes.

Key words:  Gestational diabetes      Glycodelin      HOXA-10      Leukemia inhibitory factor     
Published:  10 August 2019     
*Corresponding Author(s):  Y. AYDIN     E-mail:  dryavuzaydin@gmail.com

Cite this article: 

Y. Aydin, S. Uludağ, A. Atis, S. Uludağ, S. Ilvan. Leukemia inhibitory factor, glycodelin, and HOXA-10 in gestational diabetes. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 539-541.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4532.2019     OR     https://ceog.imrpress.com/EN/Y2019/V46/I4/539

[1] N. Al-Husban, A. Hababeh, M. Al-Kasasbeh, R. Odeh, M. Shaheen, D. Moughrabi, D. Zabalawi. Thyroid stimulating hormone (TSH) level variations in early pregnancy and feto-maternal outcome; retrospective study[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 675-680.
[2] C. Ji, L.J. Sun, L.T. Li, J. Ma, W.H. Ge, X. Zhao. Impact of clinical pharmacist intervention on blood glucose control and perinatal outcomes in gestational diabetes mellitus through a diabetes management system[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 645-652.
[3] J. A. Villarreal-Rodriguez, L. G. Mancillas Adame, J. Maldonado-Sanchez, A. Guzmán-López, O. R. Treviño-Montemayor, J. G. Gonzalez-Gonzalez, D. Saldívar-Rodríguez. A randomized controlled trial comparing acarbose vs. insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet alone[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 552-555.
[4] H.J. Wang, T.H. Chou, Y.C. Lee, H.K. Au. Acute fatty liver during pregnancy and gestational diabetes insipidus: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 438-441.
[5] Hongying Zhang, Qingling Wei, Jinlan Wei, Haiyang Pang, Wenxuan Wei, Yu Sun, Mengya He, Yanling Sun. Importance of diagnosis time on pregnancy outcomes in pregnant women with pre-gestational diabetes mellitus[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 57-61.
[6] L. Yuanmei, Z. Qian, X. Fengsen, W. Yankui. Restricted gestational weight gain in overweight/obese women with gestational diabetes mellitus and pregnancy outcomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 763-769.
[7] M. Trisovic, O. Mladenovic, J. Bila, K. Lalić, D. Kisic Tepavcevic. The predictive value of metabolic syndrome in the evaluation of pregnancy course and outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 776-778.
[8] Y. Huo, S.-X. Liu, L. Li, J. Feng, H.-Y. Li, G.-Y. Song. Circulating vaspin and IL-6 concentrations in second trimester pregnancy with gestational diabetes[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 211-215.
[9] J. Agah, F. Roodsarabi, A. Manzuri, M. Amirpour, A. Hosseinzadeh. Prevalence and associated risk factors of gestational diabetes mellitus in a tertiary hospital in Iran[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 85-89.
[10] R.A. de Jesus Pereira Araújo Barros, W. Taborda, E. Araujo Júnior, F.H. Costa Carvalho, M. da Glória Martins, A.B. Peixoto, A.M. Bertini. Predicting macrosomic newborns using postprandial glycemia of pregnancy in diabetic women[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 861-866.
[11] B. Dullaert, S. Schroven, Y. Jacquemyn. The effect of maternal vitamin D status on pregnancy outcome and child health in the first year of life[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 677-681.
[12] H. Bagci, R. Melekoglu, M.F. Gursu, A. Akyol, F. G. Bulmus. Associations between serum levels of adiponectin and resistin and metabolic parameters in pregnant women with gestational diabetes mellitus[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 539-543.
[13] Y. Yang, B.R. Luo, M. Hu, D.M. Zhao, W.J. Jing. Association of CD36 gene single nucleotide polymorphism with gestational diabetes mellitus in Chinese Han population[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 266-271.
[14] A. Ferraiolo, C. Bordone, A. Ramone, P. Sala, F. Gorlero, C. Gustavino, R. Cordera. Universal versus risk factor screening for gestational diabetes mellitus[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 53-57.
[15] A.M. Oraif, H.A. Jabar, M. Ashi, H. Al Ghanmi, A.R. Al Jarallah. Is there a relationship between maternal blood type and the incidence of gestational diabetes mellitus? A retrospective review[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 755-757.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Ibrahim Sidiqi, Patrick Alexander. Current Advances in Endovascular Therapy for Infrapopliteal Artery Disease[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 36 -50 .
[4] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[5] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[6] George L. Smith. Appropriate Use Criteria: The Gold Standard, or a Mechanism for the Derogation of Clinical Judgment?[J]. Reviews in Cardiovascular Medicine, 2011, 12(2): 105 .
[7] Prabhjot Singh Nijjar, Anoop Parameswaran, Aman M. Amanullah. Evaluation of Anomalous Aortic Origins of the Coronaries by 64-Slice Cardiac Computed Tomography[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 175 -181 .
[8] . SELF-ASSESSMENT POST-TEST[J]. Reviews in Cardiovascular Medicine, 2006, 7(S2): 51 -52 .
[9] Alice K. Jacobs. Gender Differences in Coronary Revascularization: Does Age Make a Difference?[J]. Reviews in Cardiovascular Medicine, 2004, 5(1): 68 -70 .
[10] Jeffrey W. Moses, Stephane Carlier, Issam Moussa. Lesion Preparation Prior to Stenting[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 16 -21 .